Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc van de Wetering

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Genes & Development|July 17, 2008
The intestinal stem cellNick Barker, Marc van de Wetering, Hans Clevers
Cell|May 2, 2002
WNT signaling and lymphocyte developmentMarc van de Wetering, Wim de Lau, Hans Clevers
Experimental Cell Research|May 25, 2002
Identification of two novel regulated serines in the N terminus of beta-cateninMascha van Noort, Marc van de Wetering, Hans Clevers
The EMBO Journal|July 9, 2019
Xenograft and organoid model systems in cancer researchMargit Bleijs, Marc van de Wetering, Hans Clevers, et al.
Trends in Cancer|April 4, 2025
The future of tumor organoids in precision therapySeok-Young Kim, Marc van de Wetering, Hans Clevers, et al.
The Journal of Biological Chemistry|February 13, 2004
Wnt activates the Tak1/Nemo-like kinase pathwayLinda Smit, Annette Baas, Jeroen Kuipers, et al.
The EMBO Journal|February 8, 2011
Lgr5 intestinal stem cells have high telomerase activity and randomly segregate their chromosomesArnout G Schepers, Robert Vries, Maaike van den Born, et al.
Gastroenterology|May 20, 2009
OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cellsLaurens G van der Flier, Andrea Haegebarth, Daniel E Stange, et al.
Cancers|December 10, 2021
EWSR1-WT1 Target Genes and Therapeutic Options Identified in a Novel DSRCT In Vitro ModelMargit Bleijs, Corine Pleijte, Sem Engels, et al.
Cancer Research Communications|October 12, 2023
Ewing Sarcoma Single-cell Transcriptome Analysis Reveals Functionally Impaired Antigen-presenting CellsLindy L Visser, Margit Bleijs, Thanasis Margaritis, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Genes & Development|July 17, 2008
The intestinal stem cellNick Barker, Marc van de Wetering, Hans Clevers
Cell|May 2, 2002
WNT signaling and lymphocyte developmentMarc van de Wetering, Wim de Lau, Hans Clevers
Experimental Cell Research|May 25, 2002
Identification of two novel regulated serines in the N terminus of beta-cateninMascha van Noort, Marc van de Wetering, Hans Clevers
The EMBO Journal|July 9, 2019
Xenograft and organoid model systems in cancer researchMargit Bleijs, Marc van de Wetering, Hans Clevers, et al.
Trends in Cancer|April 4, 2025
The future of tumor organoids in precision therapySeok-Young Kim, Marc van de Wetering, Hans Clevers, et al.
The Journal of Biological Chemistry|February 13, 2004
Wnt activates the Tak1/Nemo-like kinase pathwayLinda Smit, Annette Baas, Jeroen Kuipers, et al.
The EMBO Journal|February 8, 2011
Lgr5 intestinal stem cells have high telomerase activity and randomly segregate their chromosomesArnout G Schepers, Robert Vries, Maaike van den Born, et al.
Gastroenterology|May 20, 2009
OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cellsLaurens G van der Flier, Andrea Haegebarth, Daniel E Stange, et al.
Cancers|December 10, 2021
EWSR1-WT1 Target Genes and Therapeutic Options Identified in a Novel DSRCT In Vitro ModelMargit Bleijs, Corine Pleijte, Sem Engels, et al.
Cancer Research Communications|October 12, 2023
Ewing Sarcoma Single-cell Transcriptome Analysis Reveals Functionally Impaired Antigen-presenting CellsLindy L Visser, Margit Bleijs, Thanasis Margaritis, et al.
Pageof 8